Clinical Trial Update: Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating PK/PD-guided dose optimization of antibiotics to improve outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbapenem-resistant Klebsiella Pneumoniae
• Carbapenem-resistant Klebsiella Pneumoniae Bloodstream Infection

Snippet

Sponsor: Phramongkutklao College of Medicine and Hospital | Conditions: Carbapenem Resistant Klebsiella Pneumoniae | Phase 4 | Status: UNKNOWN